HDFC Bank Ltd vs Prism Medico & Pharmacy Ltd

A side-by-side comparison of HDFC Bank Ltd (HDFCBANK) and Prism Medico & Pharmacy Ltd (PRISMMEDI) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, HDFC Bank Ltd leads HDFCBANK vs PRISMMEDI on 8 of 14 metrics (4 tied). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

15.42
P/E ratio
120.40
2.11
P/B ratio
1.64
2.23%
Dividend yield
0.00%
₹49.39
EPS
₹0.24

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

13.80%
Return on equity
0.31%
7.04%
Return on capital
0.08%
0.00%
EBITDA margin
0.00%
0.00%
Net margin
0.00%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

Revenue CAGR (3Y)
19.74%
Profit CAGR (3Y)

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹12.54L Cr
Market cap
₹41 Cr
₹0 Cr
Revenue
₹28.14L Cr
₹79,219 Cr
Net profit
₹-0 Cr
0.00
Debt / equity
0.17
HDFC Bank Ltd
  • + ["Company has delivered good profit growth of 18.9% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 26.1%", "Company's median sales growth is 16.3% of last 10 years"]
  • ["Company has low interest coverage ratio.", "Contingent liabilities of Rs.35,61,957 Cr.", "Earnings include an other income of Rs.1,43,700 Cr."]
Prism Medico & Pharmacy Ltd
  • + ["Company is almost debt free.", "Stock is trading at 1.09 times its book value"]
  • ["Promoter holding is low: 30.2%", "Company has a low return on equity of 0.55% over last 3 years.", "Company has high debtors of 588 days."]
HDFC Bank Ltd full analysis Prism Medico & Pharmacy Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.